Pelvic floor muscle pain in women with endometriosis

Not Applicable

• Conditions: Endometriosis; Persistent pelvic pain; Pelvic floor muscle dysfunction; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12621000516886
• Lead Sponsor: HMRC-MRFF

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-03
• Last Update Posted: 7 June 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 151

Inclusion Criteria

•Women with pelvic pain for at least 6 months duration
•Scheduled for laparoscopy for investigation of pelvic pain, with or without sonographic evidence of endometriosis
•No prior history of surgically treated endometriosis
•Agreement to not receive physiotherapy treatment for PFM dysfunction or persistent pelvic pain between baseline assessment and 3 months post-operatively.

Exclusion Criteria

•Women who cannot have vaginal examination:
ohave never had vaginal intercourse
oare unable to tolerate vaginal examination
oare un-suitable for vaginal examination
•Pregnant, lactating, or peri-/post-menopausal women
•Inability to understand and fully comprehend consent information, including non-English speaking
•Known pathology other than endometriosis or adenomyosis as likely cause of pain
•History of or planned hysterectomy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of this study is pressure-pain sensitivity assessed using digital palpation with an attached force sensor to record the force applied during the test (called algometry). This is a partly subjective (patient report of pain, measured on a 0 – 10 pain NRS) and a partly objective (quantifiable amount of pressure applied, measured in g/kg force) measure of pressure-pain sensitivity[Time 1, baseline, before surgery is the primary time-point of the study for this outcome.<br>However this outcome will also be assessed at subsequent time-points:<br>T2: 3 months after surgery<br>T3: 12 months after surgery]